Literature DB >> 7583324

An analysis of astrocytic cell lines with different abilities to promote axon growth.

J Fok-Seang1, L C Smith-Thomas, S Meiners, E Muir, J S Du, E Housden, A R Johnson, A Faissner, H M Geller, R J Keynes.   

Abstract

The adult mammalian central nervous system (CNS) lacks the capacity to support axonal regeneration. There is increasing evidence to suggest that astrocytes, the major glial population in the CNS, may possess both axon-growth promoting and axon-growth inhibitory properties and the latter may contribute to the poor regenerative capacity of the CNS. In order to examine the molecular differences between axon-growth permissive and axon-growth inhibitory astrocytes, a panel of astrocyte cell lines exhibiting a range of axon-growth promoting properties was generated and analysed. No clear correlation was found between the axon-growth promoting properties of these astrocyte cell lines with: (i) the expression of known neurite-outgrowth promoting molecules such as laminin, fibronectin and N-cadherin; (ii) the expression of known inhibitory molecules such tenascin and chondroitin sulphate proteoglycan; (iii) plasminogen activator and plasminogen activator inhibitor activity; and (iv) growth cone collapsing activity. EM studies on aggregates formed from astrocyte cell lines, however, revealed the presence of an abundance of extracellular matrix material associated with the more inhibitory astrocyte cell lines. When matrix deposited by astrocyte cell lines was assessed for axon-growth promoting activity, matrix from permissive lines was found to be a good substrate, whereas matrix from the inhibitory astrocyte lines was a poor substrate for neuritic growth. Our findings, taken together, suggest that the functional differences between the permissive and the inhibitory astrocyte cell lines reside largely with the ECM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583324     DOI: 10.1016/0006-8993(95)00575-b

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.

Authors:  Isobel A Scarisbrick; Maja Radulovic; Joshua E Burda; Nadya Larson; Sachiko I Blaber; Caterina Giannini; Michael Blaber; Alexander G Vandell
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

2.  The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons.

Authors:  H Yamada; B Fredette; K Shitara; K Hagihara; R Miura; B Ranscht; W B Stallcup; Y Yamaguchi
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

3.  Schwann cell coculture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice.

Authors:  Xiaoyun Xu; Nicole Geremia; Feng Bao; Anna Pniak; Melissa Rossoni; Arthur Brown
Journal:  Cell Transplant       Date:  2010-11-19       Impact factor: 4.064

4.  Gene delivery to overcome astrocyte inhibition of axonal growth: an in vitro model of the glial scar.

Authors:  Hannah M Tuinstra; Melissa M Ducommun; William E Briley; Lonnie D Shea
Journal:  Biotechnol Bioeng       Date:  2012-11-01       Impact factor: 4.530

5.  PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.

Authors:  Kelly L McCoy; Stephen F Traynelis; John R Hepler
Journal:  Mol Pharmacol       Date:  2010-03-09       Impact factor: 4.436

6.  In vivo migration of endogenous brain progenitor cells guided by an injectable peptide amphiphile biomaterial.

Authors:  Reza Motalleb; Eric J Berns; Piyush Patel; Julie Gold; Samuel I Stupp; H Georg Kuhn
Journal:  J Tissue Eng Regen Med       Date:  2018-02-27       Impact factor: 3.963

7.  Discovery of a Small-Molecule Modulator of Glycosaminoglycan Sulfation.

Authors:  Sheldon T Cheung; Michelle S Miller; Reynand Pacoma; Jason Roland; Jian Liu; Andrew M Schumacher; Linda C Hsieh-Wilson
Journal:  ACS Chem Biol       Date:  2017-11-29       Impact factor: 5.100

8.  Comparison of sensory neuron growth cone and filopodial responses to structurally diverse aggrecan variants, in vitro.

Authors:  Justin A Beller; Brandon Kulengowski; Edward M Kobraei; Gabrielle Curinga; Christopher M Calulot; Azita Bahrami; Thomas M Hering; Diane M Snow
Journal:  Exp Neurol       Date:  2013-03-01       Impact factor: 5.330

Review 9.  Cell therapy for spinal cord regeneration.

Authors:  Stephanie M Willerth; Shelly E Sakiyama-Elbert
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

10.  Modification of N-glycosylation sites allows secretion of bacterial chondroitinase ABC from mammalian cells.

Authors:  Elizabeth M Muir; Ian Fyfe; Sonya Gardiner; Li Li; Philippa Warren; James W Fawcett; Roger J Keynes; John H Rogers
Journal:  J Biotechnol       Date:  2009-11-10       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.